Stock RNAC CARTESIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
36.58 USD +5.42% Intraday chart for Cartesian Therapeutics, Inc. +5.36% +76.87%
Jun. 04 Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target MT
May. 24 Mizuho Securities Starts Cartesian Therapeutics With Buy Rating MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target
MT
Mizuho Securities Starts Cartesian Therapeutics With Buy Rating
MT
Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target
MT
Mizuho Trims Price Target on Selecta Biosciences to $3 From $4, Maintains Buy Rating
MT
Needham Adjusts Price Target on Selecta Biosciences to $4 From $5, Maintains Buy Rating
MT
HC Wainwright Adjusts Price Target on Selecta Biosciences to $5 From $4, Maintains Buy Rating
MT
Mizuho Securities Adjusts Selecta Biosciences Price Target to $4 From $5, Maintains Buy Rating
MT
Canaccord Genuity Adjusts Selecta Biosciences Price Target to $9 From $10, Maintains Buy Rating
MT
HC Wainwright Adjusts Price Target on Selecta Biosciences to $4 From $6, Reiterates Buy Rating
MT
Needham Adjusts Price Target on Selecta Biosciences to $5 From $6, Reiterates Buy Rating
MT
SVB Securities Initiates Selecta Biosciences at Outperform With $7 Price Target
MT
SELECTA BIOSCIENCES : BTIG Starts Selecta Biosciences at Buy With $10 Price Target
MT
SELECTA BIOSCIENCES : William Blair Upgrades Selecta Biosciences to Outperform from Market Perform
MT
SELECTA BIOSCIENCES : Mizuho Upgrades Selecta Biosciences to Buy From Neutral, Adjusts Price Target to $8 From $2.50
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. News Cartesian Therapeutics, Inc.
  5. Analyst Reco.